Insider · CIK 0001276243

HANOVER MARC STEVEN

Reports to the SEC for 1 company · MEMPHIS, TN

sec.gov

Transactions

Companies

Filings

CIK

0001276243

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-01-01	Oncternal Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−6,397 sh	$12.71	−$81.3K	131,671
2018-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+65K sh	—	—	65,000
2017-02-28	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+95K sh	—	—	95,000
2016-10-14	Oncternal Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+123K sh	$0.81	+$100K	1,380,680
2016-01-26	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+4,000 sh	$0.65	+$2,600	1,257,224
2016-01-25	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+12.8K sh	$0.63	+$8,067.065	1,253,224
2016-01-19	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+25K sh	$0.50	+$12.4K	1,240,411
2016-01-15	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+22.1K sh	$0.49	+$10.9K	1,215,411
2016-01-14	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,900 sh	$0.47	+$1,376.92	1,193,311
2016-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+400K sh	—	—	400,000
2015-02-18	Oncternal Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+750K sh	—	—	1,190,411
2014-11-14	Oncternal Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+227K sh	—	—	440,411
2014-11-14	Oncternal Therapeutics, Inc.Common Stock Warrants (right to buy)A Award	Director, Chief Executive Officer	AAward	+227K sh	—	—	227,273
2014-09-23	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$0.75	+$3,750	213,138
2014-09-17	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$0.74	+$7,432	208,138
2014-08-21	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$1.00	+$10K	198,138
2014-08-20	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$1.00	+$10K	188,138
2014-08-19	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+8,348 sh	$1.01	+$8,448.176	178,138
2014-08-15	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1,652 sh	$1.00	+$1,652	169,790
2014-08-08	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$0.95	+$9,532	168,138
2014-08-07	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+30K sh	$0.92	+$27.6K	138,138
2014-08-07	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+20K sh	$0.92	+$18.3K	158,138
2014-06-05	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+250K sh	—	—	250,000
2013-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+90K sh	$4.20	+$378K	90,000
2012-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+70K sh	$3.36	+$235K	70,000
2011-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+70K sh	$2.65	+$186K	70,000
2010-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+70K sh	$4.20	+$294K	70,000
2009-02-19	Oncternal Therapeutics, Inc.J Other	Director, Chief Executive Officer	JOther	−250K sh	—	—	352,875
2009-01-29	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1,000 sh	$10.75	+$10.7K	108,138
2009-01-27	Oncternal Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,000 sh	$10.54	+$21.1K	107,138
2009-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+50K sh	$16.84	+$842K	50,000
2008-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+125K sh	$14.35	+$1.79M	125,000
2004-11-10	Oncternal Therapeutics, Inc.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−9,691 sh	$11.82	−$115K	41,309
2004-11-10	Oncternal Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+9,691 sh	$11.82	+$115K	311,313

Recent filings

Accepted (ET)
Jan 34
HANOVER MARC STEVEN0001179110-18-000403
SEC(opens sec.gov)
Mar 24
GTX INC /DE/0001179110-17-003656
SEC(opens sec.gov)
Oct 174
GTX INC /DE/0001179110-16-030748
SEC(opens sec.gov)
Jan 264
GTX INC /DE/0001179110-16-017994
SEC(opens sec.gov)
Jan 254
GTX INC /DE/0001179110-16-017981
SEC(opens sec.gov)
Jan 194
GTX INC /DE/0001179110-16-017834
SEC(opens sec.gov)
Jan 154
GTX INC /DE/0001179110-16-017754
SEC(opens sec.gov)
Jan 44
GTX INC /DE/0001179110-16-016935
SEC(opens sec.gov)
Feb 204
GTX INC /DE/0001179110-15-003065
SEC(opens sec.gov)
Nov 184
GTX INC /DE/0001179110-14-016763
SEC(opens sec.gov)
Sep 234
GTX INC /DE/0001179110-14-014415
SEC(opens sec.gov)
Sep 174
GTX INC /DE/0001179110-14-014247
SEC(opens sec.gov)
Aug 214
GTX INC /DE/0001179110-14-013095
SEC(opens sec.gov)
Aug 194
GTX INC /DE/0001179110-14-013030
SEC(opens sec.gov)
Aug 84
GTX INC /DE/0001179110-14-012596
SEC(opens sec.gov)

Companies

Oncternal Therapeutics, Inc.Director, Chief Executive Officer

Address

3 N. DUNLAP STREET 3RD FLOOR

MEMPHIS, TN, 38163